Die beim Kongress 2015 der European Society of Cardiology vorgestellten Leitlinien zur pulmonalen Hypertonie sind im Vergleich zur Vorgängerversion von Grund auf überarbeitet. Neu sind unter anderem die Therapiealgorithmen für die pulmonalarterielle Hypertonie und die chronisch thromboembolische pulmonale Hypertonie.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Galie N, Humbert M, Vachiery JL et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37(1):67–119
Galie N, Humbert M, Vachiery JL et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015:46(4):903–975 Kovacs G, Avian A, Pienn M et al. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med 2014;190(3):252–257
Hoeper MM, Bogaard HJ, Condliffe R et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013;62(25 Suppl):D42–D50
Eyries M, Montani D, Girerd B et al. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nat Genet 2014;46(1):65–69
Pulido T, Adzerikho I, Channick RN et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med 2013;369(9):809–818
Ghofrani HA, Galie N, Grimminger F et al. Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med 2013;369(4):330–340
Ghofrani HA, D’Armini AM, Grimminger F et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013;369(4):319–329
Galie N, Barbera JA, Frost AE et al. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med 2015;373(9):834–844
Seeger W, Adir Y, Barbera JA et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol 2013;62(25 Suppl):D109–D116
Literatur
Erstpublikation in Herz 2015;40(82): 1055-60
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olschewski, H., Kovacs, G. Pulmonale Hypertonie. Pneumo News 8 (Suppl 7), 53–58 (2016). https://doi.org/10.1007/s15033-016-0492-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-016-0492-9